Clinical Trial Update: Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating isotretinoin, interferon alfa, and vitamin E for stage III/IV head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• Interferon Alfa (interferon alfa)
• Vitamin E (tocopherol)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED